Portal vein thrombosis in a chirrotic patient with immune thrombocytopenic purpura during eltrombopag treatment İmmün trombositopenik purpuralı sirozlu bir hastada eltrombopag tedavisi sırasında portal ven trombozu

İlhan G., Acıpayam C.

Journal of Clinical and Analytical Medicine, vol.7, no.1, pp.35-37, 2016 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.4328/jcam.2540
  • Journal Name: Journal of Clinical and Analytical Medicine
  • Journal Indexes: Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.35-37
  • Keywords: Eltrombopag, Immune thrombocytopenia, Portal vein thrombosis
  • Hatay Mustafa Kemal University Affiliated: Yes

Abstract

Portal vein thrombosis (PVT) is a rare but serious complication in liver cirrho-sis. Eltrombopag is a new, second generation agent used for immune throm-bocytopenic purpura (ITP). It may cause thrombotic events. PVT has been rarely reported as a life threatening complication in some cirrhotic patients during eltrombopag using. We presented 63 years old cirrhotic and immune thrombocytopenic patient who had PVT after eltrombopag.